Repligen | RGEN - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Agilent USD 2.27B 35M 2026-03
Align Technology USD 1.91B 14.16M 2026-03
Bio Techne USD 153.28M 12.85M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Bruker USD 1.36B 75.9M 2026-03
Charles River Laboratories USD 1.09B 26.61M 2026-03
Danaher USD 7.46B 653M 2026-03
Dentsply International USD 1.21B 136M 2026-03
General Electric Aerospace USD 40.03B 1.05B 2026-03
Henry Schein USD 3.3B 69M 2026-03
Illumina USD 1.57B 19M 2026-03
IQVIA Holdings USD 8.33B 9M 2026-03
Mettler Toledo International USD 1.11B 89.76M 2026-03
Myriad Genetics USD 130.2M 3.6M 2026-03
OraSure Technologies USD 44.08M 4.29M 2026-03
Pacific Biosciences Of California USD 65.36M 7.48M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Repligen USD 126.21M 9.62M 2026-03
Revvity USD 1.24B 92.6M 2026-03
Standard Biotools USD 42.2M 66.1M 2026-03
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Waters USD 1.24B 11.8M 2025-12
West Pharmaceutical Services USD 674M 19.1M 2026-03